Europe — EMA
Orladeyo (Berotralstat)
Berotralstat, the active ingredient in Orladeyo, is a small-molecule oral kallikrein inhibitor presented as a tablet for oral use. It is indicated for the prophylactic treatment of hereditary angioedema attacks in…
Request sourcing
1
Pack/s
What is Berotralstat?
Berotralstat, the active ingredient in Orladeyo, is a small-molecule oral kallikrein inhibitor presented as a tablet for oral use. It is indicated for the prophylactic treatment of hereditary angioedema attacks in adults and adolescents aged 12 years and or younger.
GNH USA supplies Orladeyo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Berotralstat used for?
Orladeyo is a targeted re‑re re ....
What are the side effects of Berotralstat?
Common ...
What precautions apply to Berotralstat?
....
Product details
Drug
Berotralstat
Route
Oral Use
Manufacturer
Biocryst Ireland Limited
Origin
EU
